Galaxy Medical and Japan Lifeline today said they signed an exclusive distribution agreement for the Alpha1 ablation catheter. Under the agreement Galaxy will pursue U.S. regulatory approval for Japan Lifeline's Alpha1 in support of the … [Read More...] about Galaxy Medical, Japan Lifeline ink distribution agreement for ablation catheters
Main Content
Medical Tubing & Extrusion
Galaxy Medical, Japan Lifeline ink distribution agreement for ablation catheters
Galaxy Medical and Japan Lifeline today said they signed an exclusive distribution agreement for the Alpha1 ablation catheter. Under the agreement Galaxy will pursue U.S. regulatory approval for Japan Lifeline's Alpha1 in support of the … [Read More...] about Galaxy Medical, Japan Lifeline ink distribution agreement for ablation catheters
BD enrolls first patients in arteriovenous endovascular fistula post-market trial
BD (NYSE: BDX) recently announced that it has begun enrollment for its post-market surveillance study of its WavelinQ arteriovenous endovascular fistula device. The Connect-AV trial is a prospective, single-arm, open-label study that will follow … [Read More...] about BD enrolls first patients in arteriovenous endovascular fistula post-market trial
Boston Scientific initiates coronary drug-coated balloon study in U.S.
Boston Scientific (NYSE:BSX) this week launched its Agent IDE trial for its Agent drug-coated balloon. The U.S. prospective, randomized clinical trial will evaluate the safety and effectiveness of a drug-coated balloon (DCB) in patients with … [Read More...] about Boston Scientific initiates coronary drug-coated balloon study in U.S.
Endologix launches Alto abdominal stent graft in Canada
Endologix (NSDQ:ELGX) today said it launched its Alto abdominal stent graft in Canada following its recent Health Canada approval. The Alto abdominal stent graft system is a polymer-based therapy for abdominal aortic aneurysm (AAA) patients. It … [Read More...] about Endologix launches Alto abdominal stent graft in Canada
NXgenPort, Mayo Clinic ink license agreement over chemo-port catheter for home monitoring
NXgenPort today announced that it has entered into a license agreement with Mayo Clinic to develop and test an implantable chemo-port catheter. NXgenPort's technology has chemo-port efficacy with sensor technology to measure and remotely monitor … [Read More...] about NXgenPort, Mayo Clinic ink license agreement over chemo-port catheter for home monitoring
Transit Scientific scoring sheath wins CE mark
Transit Scientific today said it received CE mark clearance for its XO Score scoring sheath platform. XO Score is designed for dilation of stenotic material in the peripheral vasculature, including popliteal, infrapopliteal and native or synthetic … [Read More...] about Transit Scientific scoring sheath wins CE mark
iVascular covered stent gains CE mark
iVascular recently announced that it received CE mark approval for its BX-covered stent iCover. Balloon-expanding (BX) covered stents are used to treat arteriosclerotic lesions in renal and iliac arteries and to treat aneurysms and ruptures. The … [Read More...] about iVascular covered stent gains CE mark
